melatonin has been researched along with Pulmonary Hypertension in 13 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melatonin treatment significantly attenuated the levels of RVSP, thickness of the arteriolar wall, oxidative and inflammatory markers in the hypoxic animals with a marked increase in the eNOS phosphorylation in the lung." | 5.46 | Melatonin Attenuates Pulmonary Hypertension in Chronically Hypoxic Rats. ( Fung, ML; Hung, MW; Lau, CF; Poon, AMS; Tipoe, GL; Yeung, HM, 2017) |
| "Melatonin is a powerful antioxidant and is cardioprotective against ischemia-reperfusion injury and hypertension." | 5.42 | Melatonin as a preventive and curative therapy against pulmonary hypertension. ( Blackhurst, D; Blauwet, L; Butrous, G; Davies, N; Lecour, S; Maarman, G; Sliwa, K; Thienemann, F, 2015) |
| "Pre-treatment with melatonin (10(-4) M) showed no significant effect on the vasorelaxation by the nitric oxide donor; sodium nitroprusside (10(-7)-10(-5) M)." | 5.35 | Chronic hypoxia inhibits the antihypertensive effect of melatonin on pulmonary artery. ( Ballard, HJ; Balonan, L; Das, R; Ho, S, 2008) |
| "To determine the effect of melatonin at the transcript level of prostanoid pathways in the lung of neonatal lambs gestated and born under hypobaric hypoxia." | 3.91 | [Melatonin modulates the expression of pulmonary prostanoids]. ( Aguilar, SA; Arias, PV; Canquil, I; Ebensperger, G; González-Candia, A; Herrera, EA; Llanos, AJ; Reyes, RV, 2019) |
| "Melatonin is a neurohormone with antioxidant and vasodilator properties at the pulmonary level." | 1.56 | Melatonin long-lasting beneficial effects on pulmonary vascular reactivity and redox balance in chronic hypoxic ovine neonates. ( Aguilar, SA; Candia, AA; Ebensperger, G; Feixes, E; Figueroa, EG; Gonzaléz-Candia, A; Gonzalez-Candia, C; Herrera, EA; Llanos, AJ; Reyes, RV, 2020) |
| "Melatonin treatment significantly attenuated the levels of RVSP, thickness of the arteriolar wall, oxidative and inflammatory markers in the hypoxic animals with a marked increase in the eNOS phosphorylation in the lung." | 1.46 | Melatonin Attenuates Pulmonary Hypertension in Chronically Hypoxic Rats. ( Fung, ML; Hung, MW; Lau, CF; Poon, AMS; Tipoe, GL; Yeung, HM, 2017) |
| " This was associated with an enhanced nitric oxide-dependent and nitric oxide independent vasodilator components and with increased nitric oxide bioavailability in lung tissue." | 1.42 | Melatonin reduces oxidative stress and improves vascular function in pulmonary hypertensive newborn sheep. ( Chubretovic, M; Ebensperger, G; González-Candia, A; Herrera, EA; Llanos, AJ; Montt, C; Reyes, RV; Serón-Ferré, M; Torres, F, 2015) |
| "Melatonin is a powerful antioxidant and is cardioprotective against ischemia-reperfusion injury and hypertension." | 1.42 | Melatonin as a preventive and curative therapy against pulmonary hypertension. ( Blackhurst, D; Blauwet, L; Butrous, G; Davies, N; Lecour, S; Maarman, G; Sliwa, K; Thienemann, F, 2015) |
| "Pre-treatment with melatonin (10(-4) M) showed no significant effect on the vasorelaxation by the nitric oxide donor; sodium nitroprusside (10(-7)-10(-5) M)." | 1.35 | Chronic hypoxia inhibits the antihypertensive effect of melatonin on pulmonary artery. ( Ballard, HJ; Balonan, L; Das, R; Ho, S, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S | 1 |
| Sun, P | 1 |
| Li, Y | 1 |
| Shen, W | 1 |
| Wang, C | 1 |
| Zhao, P | 1 |
| Cui, H | 1 |
| Xue, JY | 1 |
| Du, GQ | 1 |
| Gonzaléz-Candia, A | 5 |
| Candia, AA | 1 |
| Figueroa, EG | 1 |
| Feixes, E | 1 |
| Gonzalez-Candia, C | 1 |
| Aguilar, SA | 2 |
| Ebensperger, G | 4 |
| Reyes, RV | 4 |
| Llanos, AJ | 4 |
| Herrera, EA | 5 |
| MacLean, MR | 1 |
| Rivera, E | 1 |
| García-Herrera, C | 1 |
| Celentano, DJ | 1 |
| Hung, MW | 1 |
| Yeung, HM | 1 |
| Lau, CF | 1 |
| Poon, AMS | 1 |
| Tipoe, GL | 1 |
| Fung, ML | 1 |
| Maarman, GJ | 1 |
| Veliz, M | 1 |
| Carrasco-Pozo, C | 1 |
| Castillo, RL | 1 |
| Cárdenas, JC | 1 |
| Arias, PV | 1 |
| Canquil, I | 1 |
| Jin, H | 1 |
| Wang, Y | 1 |
| Zhou, L | 1 |
| Liu, L | 1 |
| Zhang, P | 1 |
| Deng, W | 1 |
| Yuan, Y | 1 |
| Torres, F | 1 |
| Montt, C | 1 |
| Chubretovic, M | 1 |
| Serón-Ferré, M | 1 |
| Maarman, G | 1 |
| Blackhurst, D | 1 |
| Thienemann, F | 1 |
| Blauwet, L | 1 |
| Butrous, G | 1 |
| Davies, N | 1 |
| Sliwa, K | 1 |
| Lecour, S | 1 |
| Das, R | 1 |
| Balonan, L | 1 |
| Ballard, HJ | 1 |
| Ho, S | 1 |
| Backon, J | 1 |
1 review available for melatonin and Pulmonary Hypertension
| Article | Year |
|---|---|
Natural Antioxidants as Potential Therapy, and a Promising Role for Melatonin Against Pulmonary Hypertension.
Topics: Animals; Antioxidants; Biological Products; Humans; Hypertension, Pulmonary; Lung; Melatonin; Phytot | 2017 |
12 other studies available for melatonin and Pulmonary Hypertension
| Article | Year |
|---|---|
Melatonin activates the Mst1-Nrf2 signaling to alleviate cardiac hypertrophy in pulmonary arterial hypertension.
Topics: Animals; Antioxidants; Arginine Vasopressin; Cysteine; Disease Models, Animal; Familial Primary Pulm | 2022 |
Melatonin long-lasting beneficial effects on pulmonary vascular reactivity and redox balance in chronic hypoxic ovine neonates.
Topics: Animals; Animals, Newborn; Antioxidants; Arterial Pressure; Hypertension, Pulmonary; Hypoxia; Lung; | 2020 |
Melatonin: shining some light on pulmonary hypertension.
Topics: Endothelium; Humans; Hypertension; Hypertension, Pulmonary; Inflammasomes; Macrophages; Melatonin; P | 2020 |
Effects of melatonin on the passive mechanical response of arteries in chronic hypoxic newborn lambs.
Topics: Animals; Animals, Newborn; Hypertension, Pulmonary; Hypoxia; Melatonin; Pulmonary Artery; Sheep | 2020 |
Melatonin Attenuates Pulmonary Hypertension in Chronically Hypoxic Rats.
Topics: Animals; Antioxidants; Chronic Disease; Hypertension, Pulmonary; Hypoxia; Inflammation; Lung; Melato | 2017 |
Antenatal melatonin modulates an enhanced antioxidant/pro-oxidant ratio in pulmonary hypertensive newborn sheep.
Topics: Animals; Animals, Newborn; Antioxidants; Biomarkers; Birth Weight; Blood Gas Analysis; Female; Gene | 2019 |
[Melatonin modulates the expression of pulmonary prostanoids].
Topics: Animals; Animals, Newborn; Antioxidants; Hypertension, Pulmonary; Hypoxia; Melatonin; Oxidative Stre | 2019 |
Melatonin attenuates hypoxic pulmonary hypertension by inhibiting the inflammation and the proliferation of pulmonary arterial smooth muscle cells.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blotting, Western; Cell Proliferation; Hypertension | 2014 |
Melatonin reduces oxidative stress and improves vascular function in pulmonary hypertensive newborn sheep.
Topics: Animals; Animals, Newborn; Antioxidants; Hypertension, Pulmonary; Lung; Melatonin; Oxidative Stress; | 2015 |
Melatonin as a preventive and curative therapy against pulmonary hypertension.
Topics: Animals; Antioxidants; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Melatonin; Mon | 2015 |
Chronic hypoxia inhibits the antihypertensive effect of melatonin on pulmonary artery.
Topics: Animals; Chronic Disease; Disease Models, Animal; Hypertension, Pulmonary; Hypoxia; Male; Melatonin; | 2008 |
Increased serum copper in pulmonary hypertension: involvement of thromboxane?
Topics: Copper; Humans; Hypertension, Pulmonary; Melatonin; Thromboxane A2 | 1986 |